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“EVERYTHING SEEMS IMPOSSIBLE UNTIL IT IS DONE” 
 
 
 
(Nelson Mandela) 
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1. INTRODUCTION 
 
 
 
Low-income countries, such as Ethiopia, have been underrepresented amongst participating sites 
in global psychiatric genetic collaborations. For example, the large published genome-wide asso- 
ciation studies (GWAS) for schizophrenia, bipolar disorder, and major depression to date did not 
include samples from Africa and, overall, included only a small number of non-European sam- 
ples or none at all (Pardiñas et al., 2018). Recent efforts have focused on closing the gap between 
European-centered studies and those that utilize samples from other areas in the world, such as 
Asia, Middle-East, and Africa. Amongst other benefits, analyses in these samples hold the prom- 
ise of allowing for a more in-depth insight into the biology underlying previously identified sig- 
nals, e.g., allowing for fine-mapping of associations that take advantage of population-specific 
differences in linkage disequilibrium (LD) structure. Importantly, these samples will also help to 
identify new genomic regions that contribute to the etiology of psychiatric disorders (McClellan 
et al., 2017). Finally, identification and exploration of environmental risk factors specific to low- 
income countries and population-specific genetic risk loci might help to shed light on the patho- 
biology and pathopsychology of psychiatric disorders in general and improve our understanding 
of the etiology and adequate therapy in non-European settings. 
 
 
Recently, the potential role of environmental factors in the development of psychosis has been 
highlighted (van Os et al., 2010). An environmental risk factor for psychosis unique to countries 
around the Horn of Africa is the chewing of khat (Catha edulis) leaves. Khat contains am- 
phetamine-like alkaloids such as cathinone, cathine, and norephedrine, which have stimulating 
and euphorigenic effects on the central nervous system. In preparation of a future study on khat 
abuse, trauma, and psychosis in the Gilgel Gibe Field Research Center (GGFRC) in Ethiopia 
with a targeted sample size of 10,000 individuals, we have successfully conducted intertwined 
studies focusing on the assessment of phenotypes as well as environmental and genetic risk fac- 
tors. We found that the GGFRC offers a unique opportunity to build well characterized samples 
for mental health research and to perform genetic studies that so far have not been undertaken in 
Ethiopia at this scale. We also supported service development, education, and research for 
strengthening the professional profile of psychiatry and for promoting mental health according to 
the Action Plans of the World Psychiatric Association (WPA) and to the Sustainable Development 
Goals (SDG) of the United Nations (UN). 
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2. THEORETICAL BACKGROUND 
 
 
 
Khat trees are native to East Africa and the Arabian Peninsula; their leaves contain amphetamine- 
like alkaloids and are chewed for their stimulating and euphorigenic effects (Kalix, 1996). Chew- 
ing khat has a long tradition among specific ethnic groups but due to increased crop cultivation, it 
has spread further among the male population. Khat use varies by season: The dry season is char- 
 
acterized by a restricted availability and high market prices, whereas in the rainy season khat is 
abundantly available and much cheaper. Typical patterns of consumption range from moderate to 
problematic; excessive use is associated with dependence and khat-induced psychosis (Oden- 
wald, 2007). 
 
 
Psychotic disorders are serious mental illnesses that often place a high burden on patients, their 
families, and society in general, especially in low- and middle-income countries (Rossler et al., 
2005; Thornicroft et al., 2004; WHO, 2013). People with psychosis and co-morbid substance use 
disorders often experience deterioration and chronicity of psychosis and public stigma and devel- 
op additional somatic and mental health problems (Foti et al., 2010; Reta et al., 2016; Schmidt et 
al., 2011; Shibre et al., 2001). 
 
 
Subclinical psychotic symptoms are closer to the healthy state however, and severe psychotic 
disorders such as schizophrenia are at the other end of a continuum (van Os et al., 1999). Psy- 
chotic disorders are rare in the general population (e.g. lifetime prevalence of 0.7% in a large rep- 
resentative sample (Kendler et al., 1996)), but subclinical psychotic symptoms are frequent (life- 
time prevalence 28% (Kendler et al., 1996)); an authoritative review revealed that subclinical 
psychotic symptoms are transient in 75% to 90% of cases (van Os et al., 2009). Several studies 
support the continuum model, i.e. individuals with subclinical psychotic symptoms have a higher 
risk to experience significant persisting problems in social functioning and develop psychotic 
disorders later in life (Chapman et al., 1994; Fusar-Poli et al., 2012; Hanssen et al., 2005; 
Rossler et al., 2007). 
 
 
Environmental factors such as prenatal stress, malnutrition, infection, trauma, growing up in an 
urban environment and being part of an ethnic minority group are considered to be important in 
the etiopathogenesis of psychosis. Environmental risk factors associated with stress or dopamine 
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agonists might also play an important role (Collip et al., 2008; Murray et al., 2013; van Os et al., 
 
2010). An environmental risk factor unique to the countries around the Horn of Africa is the 
chewing of khat leaves, and khat is considered to be Ethiopia’s most common substance of abuse 
(Odenwald et al., 2017). Many studies found that excessive khat use can cause dependence and 
khat-induced psychotic symptoms or disorders (Odenwald, 2007; Odenwald et al., 2012; Oden- 
wald et al., 2005). Khat leaves contain amphetamine-like alkaloids, e.g. cathinone, cathine, and 
norephedrine, which have stimulating and euphorigenic effects on the central nervous system 
(Szendrei, 1980); cathinone (S (-) alpha-aminopropiophenone) is the main psychoactive compo- 
nent (Kalix, 1996; Toennes et al., 2003). Similar to amphetamine, cathinone acts at dopamine re- 
ceptors in the caudate nucleus and nucleus accumbens to increase dopamine release (Kalix, 1996; 
Wabe, 2011). Amphetamine-induced psychosis remains a matter of ongoing debate (Phillips et 
al., 2001; Poole et al., 1996): It is unclear whether amphetamine-like substances can cause psy- 
chotic disorders in healthy individuals or whether they trigger onset only in individuals with pre- 
existing, high vulnerability to the disease (Degenhardt et al., 2018; Phillips et al., 2001). 
 
 
Several studies have provided first evidence that the relationship between khat use and psychotic 
symptoms is moderated by posttraumatic stress disorder (PTSD) and trauma load (i.e. the number 
of previously experienced traumatic events) (Odenwald et al., 2009; Widmann et al., 2014). 
Odenwald et al., (2009) reported in a sample of 8,124 Somalis that the percentage of respondents 
with psychotic symptoms increased with the amount of khat use, and this association was much 
stronger among respondents with PTSD than in those without PTSD. 
 
 
Different theoretical models exist to explain the positive association of psychopathology and sub- 
stance use, e.g. the self-medication hypothesis (Khantzian, 1985), trauma hypothesis (Waldrop et 
al., 2007), and sensitization model of psychosis (Collip et al., 2008). The self-medication hy- 
pothesis proposes that drugs are used to suppress, control, inhibit or reduce negative affective 
states (Boys et al., 2003). Khantzian, (1985) observed that psychiatric patients often consume 
substances to cope with sleep disturbances, depression, or intrusive memories. Many other stud- 
ies found that especially stimulants can affect symptoms of avoidance, numbing, and comorbid 
depression (Jacobsen et al., 2001). The trauma hypothesis assumes that individuals with traumat- 
ic experiences are at higher risk to develop psychotic symptoms. Early trauma in particular has 
been repeatedly linked to various developmental stages of psychotic disorders (Brady et al., 
1998; Coffey et al., 2006; Daly, 2000). Finally, the sensitization model suggests that repeated 
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administration of amphetamines and exposure to stress can sensitize dopamine neurons and that 
the subsequent higher release of dopamine can lead to psychotic symptoms (Aiello et al., 2012; 
Redman et al., 2017). Repeated or early-life exposure to khat might increase an individual’s vul- 
nerability for psychosis (Yui et al., 2002), assuming that psychosis is the result of genetic and ac- 
quired vulnerability combined with other environmental triggers, such as traumatic experiences 
(Alemany et al., 2011; Howes et al., 2009; Robinson et al., 2015). In individuals with a vulnera- 
bility for psychosis, khat use may trigger its onset later in life or influence the course of a psy- 
chotic disorder (Odenwald et al., 2005). 
 
 
The present studies aimed to examine in representative samples the effects of the environmental 
factors khat use, assessed objectively, and exposure to traumatic experiences on the development 
of sub-clinical psychotic experiences, a potential vulnerability marker for psychotic disorders. We 
hypothesized that (1) a biological measure of khat use is associated with the presentation of sub- 
clinical khat-induced psychotic experiences, (2) the prevalence of khat-induced psychotic experi- 
ences is associated with the seasonal availability of khat, and (3) the association between khat use 
and khat-induced psychotic experiences is particularly prominent in individuals with a high trau- 
ma load. In addition, we evaluated (4) whether our findings provided further evidence for the 
sensitization model of psychosis. Furthermore, we demonstrated (5) the reliability and validity of 
research methods that are necessary for future genetic studies, i.e. the validity and reliability of 
pharmacological screening tests as well as assessments performed by trained local interviewers. 
In  addition, (6)  we  performed genome-wide genotyping in  a  smaller subset  of  our  sample 
(N=100) to demonstrate the feasibility of studying genetic risk factors and gene-environment in- 
teractions for sensitization models of psychosis, including trauma load and substance abuse. Fi- 
nally, (7) we examined various aspects of khat consumption such as withdrawal symptoms and 
also included in our studies specific population groups such as prisoners, in which we examined 
the relationship between substance use disorders and trauma. Our studies were the first psy- 
chopharmacological studies in cooperation between the Institute of Psychiatric Phenomics and 
Genomics (IPPG) in Munich, Germany, the University of Konstanz in Germany, and the Jimma 
University (JU) in Ethiopia. Under challenging conditions (high temperatures, limited refrigera- 
tion options, lack of infrastructure), we collected biological samples and analyzed them on site. 
For the High Performance Liquid Chromatography (HPLC) analyses of khat alkaloids in urine 
samples and for the DNA extraction in blood samples we established new SOPs and laboratory 
methods at JU. 
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3. METHODS 
 
 
 
3.1 STUDY FIELDS AND GENERAL CONDITIONS 
 
 
 
Our studies were conducted at Jimma University 
Specialized Hospital (JUSH), in the Correctional 
Institution in Jimma, and at the Gilgel Gibe 
Field Research Center (GGFRC) in southwestern Ethiopia. 
 
 
 
(1) Jimma University (JU) is a center of academic excellence integrating training, research and 
service development in Jimma town. It is located in the southwest of Ethiopia, about 400 km 
from the capital Addis Ababa. The University trains professionals at undergraduate and post- 
graduate levels based on the philosophy of Community Based Education (CBE). Jimma Universi- 
ty Specialized Hospital (JUSH) recently opened the largest psychiatric facility outside the capital 
Addis Ababa. The facility has outpatient services and 30 beds for inpatient care. The department 
is staffed by a full-time psychiatrist and six metal health graduates. 
 
 
Previous collaborations: In 2009, JU launched a Master of Science (MSc) in Integrated Clinical 
and Community Mental Health in collaboration with Center for International Health (CIH) at the 
Ludwig-Maximilians-University (LMU), Munich, Germany. The Ethiopian Ministry of Health 
and other stakeholders were participating in the consultative meeting for this program. The pro- 
gram aimed at educating non-physician mental health specialists who can perform various clini- 
cal, academic, administrative, and research activities in the field of mental health. The two-year 
program starting in 2010, accepted 5 to 12 students every year. After 9 years, 51 graduated from 
the program successfully. Meanwhile the master´s graduates make an important contribution to 
the mental health care in Ethiopia; they work in different and most of all in remote regions of 
Ethiopia (Soboka et al., 2018). 
 
 
(2) Correctional Institution in Jimma: The prison is managed by the Oromiya Regional Correct- 
ing Units Administrative Office. It was put into service after the expulsion of the occupying Ital- 
ian forces in 1943 and serves the following regions: Oromiya, Southern nations and nationalities, 
and Gambella region. The facility was built to accommodate 450 prisoners but currently houses 
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about 1460 (1418 male and 42 female). It is designated as a maximum-security facility. The 
prison population includes offenders on remand and people convicted to a limited or life-long 
sentence. The prison compound houses a medical clinic and sick bay, in addition to the usual 
prison facilities. 
 
 
(3) The Gilgel Gibe Field Research Center (GGFRC) is a unique health and demographic sur- 
veillance system that belongs to Jimma University. It is located 55 km northeast of Jimma and 
comprises 8 rural and 3 urban kebeles (the lowest administrative unit in Ethiopia) (s. Figure 1). 
The population is 30% urban and 70% rural, and more than 60,000 people live in the GGFRC 
(Alemseged et al., 2012). 
 
 
Figure 1. Map of Gilgel Gibe Field Research Center (GGFRC) 
 
 
 
 
 
 
 
The primary purpose of the surveillance system is to monitor indicators of basic vital events and 
generate relevant health, demographic, and socioeconomic information for policies and pro- 
grams. In addition, the center supports graduate and postgraduate level research undertakings and 
conducts molecular-to population-level collaborative research with local and international stake- 
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holders. Different need-based research projects are conducted; the main focuses of research in- 
clude malaria, causes of death assessed by verbal autopsy, maternal and child health, and chronic 
non-communicable diseases. The demographics and health of the center’s population have been 
monitored since 2005. Records are updated twice a year. People rarely refuse to comply with 
programs, because community support for the center is high. In recent years, the construction of a 
hydroelectric dam in the area has disrupted lives and livelihoods and forced many people to leave 
their homes and relocate to nearby towns and villages. The majority of residents in both urban 
and rural kebeles practice subsistence agriculture, producing mainly food crops. In the urban ke- 
beles, water is obtained from a river/stream, shallow dug well, pipes, or protected springs;  in the 
rural kebeles, it is obtained mainly from unprotected sources. The rural kebeles are accessible 
during the dry season by four-wheel drive vehicles. A recent study on risk factors for non-com- 
municable diseases found that current khat use is highly prevalent among the people living in 
GGFRC, i.e. 49.9% among males and 13.5% among females (Alemseged et al., 2012). 
 
 
 
 
RURAL KEBELE, GGFRC URBAN KEBELE, GGFRC 
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3.2 PHENOTYPIC DATA ASSESSMENT 
 
 
 
Data collection 
 
 
 
The local interviewers were highly trained and experienced staff who had conducted numerous 
assessments at JU and the GGFRC. Before the studies, they participated in an initial 5-day train- 
ing conducted by the study teams of local and international experts. The training consisted of a 
theoretical part on psychiatric experiences and interviewing rules and a practical part that includ- 
ed role plays and supervised interviews. Before expert interviews, the data collectors were re- 
trained for 3 days. Local interviewers have completed at least high school and speak Amharic and 
Afaan Oromo fluently. 
 
 
Instruments and measures 
 
 
 
Khat and other substance use: Khat chewing was assessed with an adapted version of the Time- 
line Followback (TLFB) method (Sobell and Sobell, 1992). For the interview day and the previ- 
ous seven days, respondents indicated the time they had spent chewing khat, their preferred type 
of khat, and the monetary value of the khat they had consumed. Based on two preparatory studies 
and in collaboration with local khat experts, we qualitatively defined equivalent standard units of 
different varieties of khat and their market prices. Respondents who reported no khat use in the 
previous week were classified as non-users. In most of our studies we as well asked about alcohol 
use, cigarette/shisha smoking, and use of medications and other substances in the past week. 
 
 
Psychotic experiences: On the basis of the high prevalence of khat-induced psychotic symptoms 
in previous population-based studies in khat users, we selected four items of the WHO Compos- 
ite International Diagnostic Interview (CIDI Core Version 2.1, 12 month version) (Robins et al., 
1988) to assess the related experiences (Widmann et al., 2014): G2, believing that you are being 
followed; G2b, thinking that people are talking about or laughing at you; G18, hearing things 
other people could not hear; and G21, having unusual feelings on your skin or inside your body. 
Based on of earlier studies, we defined khat-induced psychotic experiences as being present dur- 
ing or up to 6 hours after the last consumption of khat (Odenwald et al., 2017; Odenwald et al., 
2005; Widmann et al., 2014) and assessed these experiences in the last six months. Because of 
the transient nature of substance-induced psychotic symptoms, we rated experiences as positive 
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whether or not the respondent had insight into their psychotic nature and whether or not clinical 
CIDI criteria were fulfilled (e.g. the interviewer’s rating that respondent explanations are implau- 
sible). 
 
 
Traumatic experiences: We used the Life Events Checklist for DSM-5 (LEC-5) (Weathers et al., 
 
2013) to screen for potentially traumatic experiences and assessed only the events that were per- 
sonally experienced or directly witnessed by the respondents. For each item, participants re- 
sponded (yes/no) to the statement “Happened to me personally, or I witnessed it happen to some- 
one else.” 
 
 
General health: Using the approach described by Neuner et al., (2008), we asked respondents 
about minor physical complaints in the last four weeks (cough, diarrhea, influenza, fever, 
headache, stomach ache, other pain, constipation; yes/no). We also asked about problems in func- 
tioning related to mental health problems (“Because of your mental health problems, have you 
been unable to work or fulfill your household or childcare duties during the last four weeks?”) 
and help-seeking for mental health problems (“Have you ever sought help because of mental 
health problems, e.g. from a traditional healer, religious authority, pharmacy or medical doctor?). 
 
 
Further instruments: In many studies we have additionally used the following instruments: We 
assessed the presence of alcohol use disorder (AUD) with the Alcohol Use Disorders Identifica- 
tion Test (AUDIT) (Babor et al., 2001) and of nicotine dependence by the Fagerstrom Test for 
Nicotine Dependence (FTND) (Heatherton et al., 1991). To evaluate khat abuse we also used the 
Drug Abuse Screening Test (DAST) (Wazema et al., 2017).  In addition, cannabis use disorder 
(Cannabis Use Problems Identification Test, CUPIT) (Bashford et al., 2010), psychopathy (Psy- 
chopathy Checklist) (Hart et al., 1995), and social support (Oslo 3-item Social Support Scale) 
(Bøen et al., 2012) were assessed. 
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3.3 BIOLOGICAL MEASURES 
 
 
 
Few studies have addressed methodological issues related to the assessment of khat use, and very 
little research has attempted to validate research methods that are suitable for field conditions, 
especially in rural areas which are highly populated by khat users, where electrical power is un- 
available and pharmacological laboratory infrastructure not accessible. Khat research is ham- 
pered by a lack of validated research methods that can feasibly be used in field conditions, i.e. in 
areas where most khat users live, far away from sophisticated laboratory infrastructure. There- 
fore, our aim was to develop khat assessment methods with low resource requirements in order to 
monitor khat use comprehensively and effectively. 
 
 
Urine sampling: Urine samples were collected in a clean, wide-mouth standard urine container 
with a screw cup. During sample collection, containers were codified with robust adhesive labels. 
Immunoassay tests were performed at the local health centers by trained pharmacological assis- 
tants or nurses. Urine samples collected for HPLC were stored in the refrigerators at the local 
health centers until transported to the laboratory at JU. During transportation to JU, urine samples 
were stored in battery-powered cold boxes. The mean time from sample collection in the GGFRC 
until arrival at JU was 299.24 min (minimum 95 min, maximum 495 min). Refrigeration was un- 
interrupted during transportation and storage at JU. In the laboratory at JU, urine samples were 
stored according to standard procedures under controlled temperature conditions and appropriate 
refrigeration (2-8˚C) until the analysis was conducted. 
 
 
Urine-based immunoassay test: Khat alkaloids in the respondents’ urine were assessed by a sim- 
ple amphetamine immunoassay test (Nal van Minden, Moers, Germany, AMPH mono test, sensi- 
tivity 300 ng/ml). In a pre-study in khat users, the test showed good sensitivity and specificity. 
The test is simple and can be used under field conditions (i.e. at local health centers). 
Odenwald et al., (2009) conducted two studies in Somalia to validate commercially available 
immunoassay tests for detecting and measuring khat alkaloids in urine samples. The tests were 
standard urine tests for measuring amphetamines: the Combur-10 test (Roche, Switzerland), 
Oekonomed single amphetamine test (Rödinghausen, Germany), and Diagnostik Nord Multi 5-1 
drug test (Schwerin, Germany) (Odenwald et al., 2009; Odenwald et al., 2005). All three tests 
positively detected amphetamines and produced negative results for all other types of drugs. The 
authors found that both cathine and cathinone can be measured by commercially available tests 
for amphetamines and that these urine tests are useful and feasible under field conditions in So- 
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malia (Odenwald et al., 2009). In addition, various other research groups have recently used dif- 
ferent immunoassays to successfully detect cathinones and synthetic cathinones (Toennes and 
Kauert, 2002; Ellefsen et al., 2014; Namera et al., 2015; Swortwood et al., 2014). However, the 
sensitivity of these tests was found to be weak and only excessive khat use appeared to produce a 
positive test result. Primary analyses revealed that this was also the case for the AMPH 1000 test, 
and therefore only the results of the AMPH 300 will be reported. 
 
 
HPLC-based assessment of khat alkaloids: To detect khat alkaloids in urine samples, we used the 
HPLC method, which was positively evaluated in previous studies (Yi et al., 2013; Atlabachew et 
al., 2016; Atlabachew et al., 2017; Morad et al., 1989; Toennes and Kauert, 2002; Toennes et al., 
2004)). Toennes and Kauert were among the first researchers to use the HPLC method to analyze 
urine samples of khat users (Toennes and Kauert, 2002). Khat alkaloids were detected in urine 
samples up to 34 hours after khat chewing, and in one case even up to 50 hours afterwards 
(Toennes and Kauert, 2002). Not studied at all were biases that are typical for the assessment of 
self-reported data, e.g. social desirability, which might cause underreporting of substance use. 
Our first aim was to determine the degree of concordance between assessment methods with low- 
resource requirements that are feasible for field research, i.e. interviews with trained laypersons 
and simple immunoassay tests originally developed to measure amphetamines, and large-scale 
application and gold standard assessment methods with high resource requirements and thereby 
to assess the validity of the low-resource methods. Our second aim was to deepen our under- 
standing of self-reported khat use, i.e. how specific aspects relate to the biological measures. 
Therefore, we analyzed norephedrine (NE) as the sole marker for khat alkaloids because it is one 
of the main, stable alkaloids that can still be detected more than one day after khat use, and it is a 
legal substance in Ethiopia. 
 
 
Reference preparation: Twenty Recatol® capsules were weighed, the contents removed and the 
average weight of each capsule calculated. About 50 mg NE-equivalent weight of Recatol® was 
mixed with 10 ml of water, and the pH was adjusted to 9 by adding NaOH. NE was extracted via 
10 ml of dichloromethane:diethylether (mix 1:1); this step was conducted twice. The organic in- 
gredients were removed with a separatory funnel, and the aqueous part containing NE was evapo- 
rated to dryness. Finally, the dry residue was dissolved in 100-500 μl methanol and analyzed by 
HPLC. 
 
 
Urine sample preparation by solid phase extraction (SPE): SPE was performed with Agilent Vac 
 
Elut 12 Manifold and Bond Elut LRC-Certify, 300 mg. Urine samples were conditioned at room 
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temperature. Then, 1.0 ml of the urine sample was diluted with 4.0 ml of phosphate buffer. The 
SPE column was conditioned with 3.0 ml methanol and 3.0 ml phosphate buffer. The diluted 
sample was applied on the SPE column and extracted with a vacuum sucker at a pressure of 5 
inHg. The sample was washed from the column by the application of 2.0 ml of 0.1M acetic acid 
and 3.0 ml of methanol. Then, the sample was eluted from the column into a new test tube by 3.0 
ml of dichloromethane : isopropanol : ammonia (80:20:2, v/v) and evaporated to dryness. Finally, 
the sample was dissolved into 2.0 ml of diluents solvent and analyzed by HPLC. 
 
 
Preparation of reagents: Mobile phase buffer solution was freshly prepared by dissolving 13.6 g 
potassium phosphate monobasic (KH2PO4) in 1000.0 ml water. Mobile phase was then freshly 
prepared by mixing 30.0 ml methanol with 970 ml mobile phase buffer solution. The solution 
was then filtered through a 0.45 μm nylon filter and degassed under vacuum. For conditioning, 
3.0 ml methanol and 3.0 ml phosphate buffer (0.1M, pH 6) was used. For the SPE washing solu- 
tion, 2.0 ml acetic acid (i.e. 5.73 ml glacial acetic was added to water adjusted to 1 L to obtain 0.1 
M) and 3.0 ml methanol were used. As the SPE elution solvent, 3.0 ml dichloromethane : iso- 
propanol : ammonia (25%; 80:20:2, v/v) was used. Diluents were prepared by mixing 30.0 ml 
methanol with 970.0 ml water. Then, 1.3 g KH2PO4 was added and stirred until all the salt was 
dissolved, then the whole solution was degassed. 
 
 
HPLC-results: The typical chromatograms obtained on Recatol® reference standard solution and 
the urine extracts is presented in Figure 2. NE elutes at an average retention time of 5.7 min with 
peak asymmetry As of 1.1 and retention factor k’ of 4.2. The number of theoretical plate N was 
calculated to be 1156 indicating good separation efficiency of the column. Method validation re- 
sults indicated the fitness-for-use of the applied HPLC method. The 95% CI for the regression 
slope = 5.925 (95% CI: 5.796 to 6.053) and y-intercept = 3.476 (95% CI: -25.960 to 32.913) to- 
gether with r2 value of 0.999 and ANOVA F-value of 21548 proved a strong positive linear rela- 
tionship. Percentage relative standard deviation for repeatability (%RSD= 0.10) of the method 
were within the specification limit (%RSD ≤2). Limit of detection (LOD) for this method was 
0.04 µg/ml and limit of quantification of 0.14 µg/ml show that the method fits for both qualitative 
and quantification analysis. Before analysis, the samples were inspected for integrity and found to 
be stable to the storage condition. 
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Figure 2. HPLC-results: Norephedrine (NE) elutes at an average retention time of 5.7 min with peak 
asymmetry. 
 
 
A) RECATOL (reference standard) B) URINE SAMPLE   
 
 
 
 
 
 
Urine samples: A total of 126 urine samples were extracted using the solid-phase extraction 
(SPE) apparatus and analysed by HPLC. The results showed that 81 (64.3%) samples were posi- 
tive and the remaining 45 (35.7%) samples were negative for NE. For positive urine samples, the 
NE content ranges from 2.3 to 161.1 µg/ml, with an average NE content of 36.7 µg/ml. 
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3.4 GENETIC ANALYSES 
 
 
 
We performed genome-wide genotyping in a smaller subset of our pilot sample (N=100). This 
pilot study was conducted to demonstrate the feasibility of studying genetic risk factors and gene- 
environment interactions for sensitization models of psychosis, including trauma load and sub- 
stance abuse, in the full Ethiopian cohort of 10,000 individuals. We collected blood samples (10 
ml venous blood). The samples were transported to the study laboratory by a cold chain system 
preserving the integrity of the sample and stored in refrigerators at 2-8 °C after reaching the labo- 
ratory. Subsequently, blood samples were transported to JU and stored in freezers (-80̊C). The 
average time from sample collection at the GGFRC until arrival at JU was 299,24 min (range 95- 
495 min). For DNA extraction, we established state-of-the-art procedures on site: DNA was ex- 
tracted using chemagic DNA Blood 10k Kits (Perkin Elmer). The purity and homogeneity of the 
samples were tested by spectrophotometric measurements. For photometric determination of the 
DNA concentration, we used BioPhotometer instruments with absorbance measured at 260 nm. 
The samples were genome-wide genotyped using the Infinium Global Screening Array BeadChip 
(Illumina). This BeadChip includes multi-ethnic genome-wide content which was selected at mi- 
nor allele frequencies of >1% across all 26 1000 Genomes Project populations, including cohorts 
from Africa (Huang et al., 2011; Ha et al., 2014; Auton et al., 2015). We also performed down- 
stream analyses of our GWAS pipeline to further assess the quality and usability of our data. This 
included a principle component analysis (PCA) using the EIGENSOFT software package (with 
default parameters) as well as an example GWAS on NE concentration in urine for our study 
sample (Li Q et al., 2008). 
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4. PRESENTATION OF THE HABILITATION-RELEVANT ORIGINAL WORKS 
 
 
 
4.1 Adorjan K, Odenwald, M., Widmann M, Tesfaye M, Tessema F, Toennes S, Suleman S, Pa- 
piol S, Soboka M, Mekonnen Z, Rietschel M, Pogarell O, Susser E and Schulze TG. Khat (catha 
edulis) use and the occurrence of psychotic symptoms in the general population in Southwestern 
Ethiopia: suggestive evidence for sensitization by traumatic experiences. World Psychiatry. 2017 
16(3):323. 
 
 
 
Introduction 
 
 
 
The sensitization model of psychosis suggests that repeated exposure to amphetamines or stress 
can sensitize dopamine neurons. Khat leaves contain amphetamine-like alkaloids, and heavy use 
is frequently associated with psychotic symptoms. We studied how seasonal variations in khat 
availability and exposure to traumatic events affect khat-induced psychotic experiences. At 
GGFRC of JU, we randomly selected a representative cohort of 1,100 men aged 18 to 40 years; 
853 (77.5%) agreed to participate. We interviewed participants during the dry season, when khat 
availability is restricted, and nine months later, just after the rainy season (n = 695; 81.5% of ini- 
tial sample). We assessed self-reported khat use, khat-induced psychotic experiences, and expo- 
sure to potentially traumatic experiences. Khat alkaloids were determined in urine by immunoas- 
say. Khat use and khat-induced psychotic experiences were more prevalent during the rainy sea- 
son and in participants with a positive immunoassay and higher trauma load. During the rainy 
season, khat use and trauma interacted and increased the prevalence of khat-induced psychotic 
experiences. Recent and lifetime trauma were equally associated with more khat-induced psy- 
chotic experiences. Our findings support that environmental factors and sensitization might be 
related to the development of psychotic experiences but need to be replicated in larger, longer 
studies that assess psychotic experiences and symptoms more comprehensively. 
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Methods 
 
 
 
Study population: This study was conducted at the GGFRC. We used a two-stage process to ran- 
domly select 1,100 male adults (18-40 years) from the GGFRC central database. First, we ran- 
domly chose two urban and three rural clusters. Then, we randomly selected participants on the 
basis of the overall proportion of the cluster subpopulation size. Inclusion criteria were male sex, 
age 18-40 years, residency in the GGFRC for at least 6 months, and fluency in Amharic or Afaan 
Oromo. We recruited only men because in the GGFRC significantly more men than women use 
khat (Alemseged et al., 2012). We chose the age range because khat use typically starts in young 
adulthood, khat is used mostly by young males, and psychotic experiences usually appear for the 
first time at a young age (Kebede et al., 2005; McGrath et al., 2016; Reda et al., 2012). Exclu- 
sion criteria were plans to relocate within the study period, severe alcohol or other substance 
abuse, and severe developmental and neurological disorders. 
 
 
Study design: Trained local interviewers assessed the participants twice at nine-month intervals 
(T1 and T2) to determine khat use and traumatic experiences and the presence and stability of 
distinct khat-induced psychotic experiences. At T1 and T2, urine samples were collected and as- 
sessed for khat alkaloids by immunoassay. T1 was in the dry season (February and March 2015), 
when khat supply was limited and khat was expensive, and T2 was shortly after the rainy season 
(November and December 2015), when khat was abundantly available at local markets and prices 
were low. 
 
 
Validation sub-study: The validity of the data was confirmed by clinical validation interview con- 
ducted shortly after T1 (mean [SD] 2.0 [1.9] days after T1) by mental health specialists, who re- 
assessed psychotic experiences and khat and alcohol use in a randomly selected subgroup of 124 
individuals. In this subgroup, we obtained an additional urine sample, which was refrigerated un- 
til being transported to JU laboratory for analysis by HPLC to validate the immunoassay results 
(European Directorate for the Quality of Medicines, 2006; Roman, 2004; Toennes and Kauert, 
2002). We chose the khat alkaloid NE as the single reference substance for practical reasons (it is 
detectable for longer periods, and the pure substance is not illegal in Ethiopia). To control for NE 
consumption in common cold medications, we assessed the use of these medications and subse- 
quently excluded 4 participants from the validation study. The immunoassay and HPLC (refer- 
ence) showed a moderate agreement (unweighted kappa .419). Specificity was perfect (1.00), but 
sensitivity was only moderate (.506) because, in contrast to HPLC, immunoassay cannot detect 
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small amounts of khat alkaloids; in line with this, the urine level of NE in respondents with a 
negative immunoassay who reported khat chewing was significantly smaller than in respondents 
with a positive immunoassay (p < .001). Consequently, we considered the immunoassay test 
rather a screening measure for heavy khat use only. Immunoassay also showed moderate agree- 
ment with self-reported khat use (because of the typical metabolism of khat alkaloids, we used 
self-reported khat use for the day of the sampling plus the day before as reference), with an un- 
weighted kappa of .453, a specificity of .675, and a sensitivity of .827. In sum, the results of the 
validation sub-study support the validity of the immunoassay tests used. 
 
 
Instruments and measures (s. above - here only supplemented with some study-specific informa- 
tion) 
 
 
Khat and other substance use: Khat chewing was assessed with an adapted version of the Time- 
line Followback (TLFB) method (Sobell and Sobell, 1992). A comparison of khat use assessed by 
the trained local interviewers and by trained mental health experts confirmed the validity of the 
assessment (kappa = .798; p <.001); in the expert interview, 76.0% of participants (n = 111) re- 
ported khat use in the previous week. 
 
 
Psychotic experiences: On the basis of the high prevalence of khat-induced psychotic symptoms 
in previous population-based studies in khat users, we selected four items of the WHO Compos- 
ite International Diagnostic Interview (CIDI Core Version 2.1, 12 month version) (Robins et al., 
1988) to assess the related experiences (Widmann et al., 2014) (s. above). We calculated a di- 
chotomous variable from the responses to the four items, i.e. whether or not any khat-induced 
psychotic experience was reported. The agreement between local interviewers and mental health 
experts was moderate (kappa = .553); specificity was high (.934) and sensitivity, moderate (.576). 
In sum, the validity of the local interviewer ratings was acceptable for our analysis because the 
majority of cases and non-cases were correctly classified. In the validation sub-study, the agree- 
ment of khat-induced psychotic experiences with true psychotic symptoms (assessed by mental 
health experts) was small (Phi = .276, p = .002): 65% (n = 80) had no psychotic symptom or ex- 
perience, 10% (n = 12) had both types of psychotic phenomena, 17% (n = 21) had only khat-in- 
duced psychotic experiences, and 9% (n = 11) had only true psychotic symptoms, i.e. more than 
half of those with true psychotic symptoms also had khat-induced psychotic experiences. 
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Traumatic experiences. We used the Life Events Checklist for DSM-5 (LEC-5) (Weathers et al., 
 
2013) to screen for potentially traumatic experiences and assessed only the events that were per- 
sonally experienced or directly witnessed by the respondents. At T1, we used the LEC-5 to assess 
previous traumatic experiences (exposure before T1); and at T2, to assess events in the nine 
months since T1 (recent exposure). Lifetime exposure was defined as the sum of events reported 
at T1 and T2. We used a median split to build two groups (low vs. high lifetime exposure): ≥4 
lifetime traumatic events corresponded with a high trauma load, and ≤3, with a low trauma load. 
Exposure before T1 was defined as ≥3 previous traumatic events. All respondents who reported at 
least one recent event at T2 were included in the group with recent exposure. 
 
 
General health: Using the approach described by Neuner et al., (2008), we asked respondents 
about minor physical complaints in the last four weeks (s. above). We recorded a “1” for each 
complaint that achieved an acceptable Cronbach’s alpha of .656 and then calculated a sum score 
to represent participants’ general physical health. 
 
 
Immunoassay tests: Khat alkaloids were assessed in urine by simple immunoassay tests (Nal van 
 
Minden immunoassay test, Nal van Minden, Moers, Germany; amphetamine mono test, cut-off 
 
300 ng/ml) at T1 and T2. Urine samples were collected in a clean wide-mouth standard urine 
container with a screw cup and transported within hours to a local health center, where they were 
refrigerated. 
 
 
Statistical analysis: We tested for group differences with paired t-tests and McNemar’s test and 
evaluated whether khat use differed in the four subgroups (trauma load * test result) with a two- 
factorial analysis of variance (ANOVA). We evaluated the effect of khat alkaloids and trauma 
load on psychotic experiences with Chi2 tests; the null hypothesis was that the cell frequencies in 
the 2*2 (trauma load * test result) and 2*2*2 tables (trauma load high vs. low * immunoassay test 
positive vs. negative * khat-induced psychotic experiences present vs. absent) were equally dis- 
tributed. We repeated this analysis in a 2*2*2*2 table by splitting the trauma factor into exposure 
before T1 and recent exposure (between T1 and T2). For the graphical presentation, we calculat- 
ed the standard error of sample proportions by binomial distribution. Furthermore, we used bina- 
ry logistic regression to test whether khat-induced psychotic experiences can be statistically ex- 
plained by the immunoassay test for khat alkaloids (positive vs. negative) or trauma load (median 
split; high vs. low trauma load), or their interaction. These three terms were entered simultane- 
ously into the model, together with a constant term. We did not control for socio-demographic 
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variables and studied main and interaction effects. To increase power, we restricted this binary 
logistic regression model to respondents who reported khat use in the previous week. 
 
 
Results 
 
 
 
Comparison at T1 and T2: At T2, 695 (81.5%) of the 853 respondents at T1 were reassessed. Ta- 
ble 1 shows the sample characteristics at T1 and T2. The mean age at T2 did not differ signifi- 
cantly from T1; however, the 158 respondents who could not be reinterviewed at T2 were slightly 
younger than the rest of the sample (mean [SD] age 27.5 [6.5] years; p = .045; Hedge’s g = .178). 
The proportion of participants reporting mental health-related problems in functioning and hav- 
ing ever sought mental health assistance decreased significantly from T1 to T2; however, rates of 
help-seeking (p = .794) and problems in functioning (p = .291) were similar in participants who 
did not participate at T2 and those who did. Reported physical complaints decreased significantly 
from T1 to T2. Participants who dropped out reported a similar number of physical complaints (p 
= .737) and of potentially traumatic experiences at T1 (p = .438). 
 
 
 
Table 1: Sample characteristics of male khat users at the initial assessment (T1, dry season) and 9-month 
follow-up assessment (T2, rainy season). For age, traumatic experiences, and the sum of physical com- 
plaints, we report an independent t-test between the participants included at T2 and those who had 
dropped out; for all other variables, we performed a paired McNemar’s test. *n values vary because of 
missing data. 
 
  T1 (N = 853) T2 (N = 695) p 
Mean (SD) age in y 28.4 (6.6), (n = 850) 28.6 (6.6), (n = 693) .045 
Self-reported khat use in the past week, % (n/N*) 72.1 (606/841) 80.1 (555/693) <.001 
Positive immunoassay test, % (n/N*) 28.3 (239/813) 36.9 (246/666) <.001 
Alcohol use in the past week, % (n/N*) 6.9 (58/842) 6.2 (53/694) .121 
Cigarette or shisha use in the past week, % (n/N*) 13.3 (105/791) 16.0 (110/688) .141 
Medication and other substance use in the past week, % (n/N*) 10.3 (86/831) 17.9 (124/691) <.001 
Problems in functioning in the past 4 weeks due to mental health 
problems, % (n/N*) 
4.1 (35/842) 1.4 (12/693) .001 
Ever sought help because of mental health problems, % (n/N*) 2.3 (19/841) 0.7 (5/694) .003 
Khat-induced psychotic experiences in the past 6 months, % (n/ 
N*) 
7.9 (67/853) 12.8 (89/693) .001 
Physical complaints in the past 4 weeks, mean (SD) 2.0 (1.8), n = 843 1.6 (1.6), n = 694 .001 
Potentially traumatic experiences, mean (SD) 3.2 (2.5), n = 842 0.5 (0.9), n = 694 .438 
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Prevalence of khat use, psychotic experiences, and traumatic experiences: At T1, 599 (71.1 %) 
individuals reported khat use in the previous week, and at T2, 565 (81.4%; p < .001). Immunoas- 
say tests were positive in 28.3% (T1) and 36.9% (T2; p <.001) of all samples (khat users and 
non-users) and in 37.6% (T1) and 44.2% (T2) of khat users. The 6-month prevalence of khat-in- 
duced psychotic experiences was 7.9% at T1 and 12.8% at T2 (p = .001). 
 
 
The cross-tabulation reported in Table 2 shows the great variability in the prevalence of khat-in- 
duced psychotic experiences between the dry and rainy season: 70.8% of the respondents with 
khat-induced psychotic experiences at T2 had none at T1, and 54.4% of the respondents with 
these experiences at T1 had none at T2. 
 
 
Table 2. Cross-tabulation of khat-induced psychotic experiences in a sample of male khat users between 
the assessments in the rainy season (T2; n = 695) and dry season (T1; n = 853). We report frequencies and 
percentages of the total sample. 
 
 
Khat-induced psychotic experiences at T2 
 
Sum 
No Yes n, 
%  n, % 
 
 
Khat-induced psychotic expe- 
riences at T1 
No 573, 63, 636, 82.7% 9.1% 91.8% 
Yes 31, 26, 57, 4.5% 3.8% 8.2% 
Sum 604, 89, 693, 87.2% 12.8% 100% 
 
 
 
 
A total of 743 (87.1%) respondents reported at least 1 event on the LEC-5 before T1, and 206 
(29.7%) reported at least 1 event during the 9 months between T1 and T2. A mean of 3.7 (SD 2.7) 
events were reported. The most common potentially traumatic experiences were fire or explosion 
(64.5%), physical assault (51.0%), unexpected death of close people (33.9%), life-threatening 
illness/injury (30.8%), transportation accident (25.8%), severe human suffering (24.2%), assault 
with a weapon (21.3%), and natural disaster (19.9%). 
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Predicting psychotic experiences by khat use and traumatic experiences 
 
 
 
Dry season (T1): Of the 853 respondents, 813 could be included in the analysis (95.3%; data 
were missing for the remaining 40), which was based on a 2 (high vs. low trauma load) * 2 (posi- 
tive vs. negative immunoassay test) * 2 (with vs. without khat-induced psychotic experiences) 
table. The percentage of khat-induced psychotic experiences was highest (16.6%) in the group 
with a positive immunoassay test and high trauma load (s. Figure 3). 
 
 
Figure 3. Predicting psychotic experiences by khat use and traumatic experiences. Dry season 
 
T1: Khat-induced psychotic experiences 
20 
 
16,2 
 
15 
 
 
 
10 
 
 
5,8 
05 
 
8,0 7,8 
 
 
 
00 
 
 
% Neg Amph Test % Pos Amph Test 
 
 
 
The 2*2 table (low trauma load * positive immunoassay test) with the 489 respondents with a 
low trauma load did not reach statistical significance (Chi2 = 0.780, df 1, p = .377). In the 324 
respondents with a high trauma load, both the 2*2 table (Chi2 = 5.367, df 1, p = .021) and the 
total 2*2*2 table (Chi2 = 6.112, df 1, p = .013) were significant. The binary logistic regression 
model with the 813 respondents in which the trauma load and immunoassay test and their interac- 
tion were entered into a single block achieved a significant overall fit (Chi2 = 10.281, df 3, p = . 
016). No significant main effects (trauma load: OR = 1.375, CI 95% .709-2.667, p = .347; im- 
munoassay test: OR = 1.420, CI 95% .650-3.105, p = .379) or a significant interaction effect (OR 
= 1.616, CI 95% .559-4.671, p = .375) were detected. We repeated the binary logistic regression 
model in the current khat users (n = 599, 70.2% of the T1 sample): 580 could be included, and 
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the model did not achieve a significant fit (Chi2 = 6.627, df 3, p = .085). Neither the main effects 
nor the interaction effect was significant (p > .308). 
 
 
Rainy season (T2): At T2, 693 respondents were re-assessed, and 661 (95.4%) were included in 
the analysis. Similar to T1, the percentage of khat-induced psychotic experiences increased with a 
positive amphetamine urine test and high trauma load (s. Figure 4). Among those with a low 
trauma load (n = 350), a positive urine test was not related to the proportion of khat-induced psy- 
chotic experiences (Chi2 = 3.370, df 1, p = .066), but in those with a high trauma load (n = 311), 
it was associated with a higher proportion of khat-induced psychotic experiences (Chi2 = 21.261, 
df 1, p < .001). The overall test for the whole 2* 2*2 table was also significant (overall Chi2 = 
22.909, df 1, p < .001). 
 
 
 
Figure 4. Predicting psychotic experiences by khat use and traumatic experiences: Rainy season 
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The binary logistic regression model with all 661 respondents achieved a good model fit (Chi2 = 
 
28.140, df = 3, p < .001). The main factor trauma load did not achieve significance (OR = .949, 
CI 95% .459-1.962). Both the immunoassay test main effect and the interaction effect showed a 
trend towards significance (immunoassay: OR = 1.916, OR 95% .948-3.871, p = .070; trauma * 
immunoassay: OR = 2.339, CI 95% .883-6.197, p = .088). When the binary logistic regression 
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model was limited to khat users (because of missing data, 540 of 565 khat users were included), 
we found a good model fit (Chi2 = 18.697, df 3, p < .001). There was no main effect of trauma 
load (OR = .829, CI 95% .388-1.774, p = .630) or immunoassay test (OR = 1.314, CI 95% . 
634-2.724, p = .463), but a significant interaction effect of amphetamine test * trauma load (OR = 
 
2.822, CI 95% 1.030-.732, p = .044). In an additional analysis, we evaluated khat use in the four 
groups to investigate whether the higher proportion of khat-induced psychotic experiences in 
some subgroups might simply be related to a higher khat use, i.e. positive or negative immunoas- 
say * high or low trauma load * hours of khat use in the previous week in the dry (T1) and rainy 
(T2) seasons (s. Table 3). There were no significant differences. 
 
 
Table 3. Hours of actual khat use in participants who used khat in the week before the assessments T1 
(dry season; n = 853) and T2 (rainy season; n = 695) and had a high or low trauma load. 
 
Low Trauma Load High Trauma Load 
ANOVA 
 
(1) (2) (3) (4) 
Neg Test1 Pos Test1 Neg Test1 Pos Test1 
 
 
 
Post hoc t- 
test2 
 
Mean (SD) 
hours of khat 8.28 15.12 
8.58 (8.79), 
19.41 Trauma: p = .028 
use (past week) (9.88), (14.16), n = 144 (16.86), Immunoassay: p < .001 
in the dry sea- n = 218 n = 117 n = 101 Interaction: p = .057 
son (T1) 
(1) vs. (3): p = 
.765 
 
(2) vs. (4): p = 
.043 
 
Mean (SD) 
hours of khat 
12.52 (12.21), 
23.68 
16.88 (17.05), 
26.25 Trauma: p = .029 
use (past week) n = 157 (21.33), n = 141 (21.70), Immunoassay: p < .001 
in the rainy n = 112 n = 121 Interaction: p = .565 
season (T2) 
(1) vs. (3): p = 
.013 
 
(2) vs. (4): p = 
.368 
 
1.  Presence of khat alkaloids in urine were tested with the Nal van Minden immunoassay test; Neg: negative; Pos: 
positive. 
2.  Bonferroni correction, alpha = .025 
 
 
 
 
 
Effect of recent and lifetime trauma on khat-induced psychotic experiences: To study the effect of 
recent vs. lifetime exposure to potentially traumatic events, we analyzed the data of the 660 re- 
spondents who reported potentially traumatic experiences at T1 and T2 and compared rates of 
reported khat-induced psychotic experiences in a 2*2*2*2 table, i.e. (low vs. high trauma load 
before T1) * (with vs. without recent trauma in 9 months before T2) * (positive vs. negative im- 
munoassay test) * (with vs. without khat-induced psychotic experiences). The rates of reported 
khat-induced psychotic experiences among the groups with negative immunoassay tests ranged 
from 6% to 12%; and among the ones with positive test results, from 11% to 29% (s. Figure 5). 
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In the sub-sample of 399 respondents who reported low trauma exposure before T1, 28.9% of the 
respondents with recent trauma exposure and a positive immunoassay had khat-induced psychot- 
ic experiences. Among the 261 respondents with trauma exposure before T1, the two groups with 
trauma exposure and a positive immunoassay reported similarly high rates of khat-induced psy- 
chotic experiences, irrespective of whether the trauma exposure was recent (25.0%) or not 
(25.8%). 
 
 
Figure 5. Effect of recent and lifetime trauma on khat-induced psychotic experiences 
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Discussion 
 
 
 
This study found first potential evidence that the prevalence of khat-induced psychotic experi- 
ences might be increased by two environmental factors: higher seasonal khat availability and 
greater exposure to traumatic experiences. This study is the first to report on this potentially seri- 
ous problem in Ethiopia. The findings may be relevant in other low-income countries where khat 
chewing is highly prevalent. Recent exposure to traumatic events seemed to have the same effects 
on psychotic experiences as lifetime exposure. The rate of khat-induced psychotic experiences 
was highest among respondents with high exposure to traumatic events and a positive khat alka- 
loid test; more extreme khat use did not explain the higher rate in this subgroup. As such, our data 
might support the interpretation that these two environmental factors interacted with each other in 
participants with recent or lifetime exposure to traumatic events to make them more susceptible 
to the psychotomimetic effects of khat. This suggested interaction needs further proof, but it is 
alarming that large parts of a population are exposed to khat alkaloids. Although it is unsurprising 
that higher khat use could be related to higher rates of khat-induced psychotic experiences, the 
hypothesis that higher vulnerability to psychotic symptoms might result from the interaction of 
the two environmental factors is important and warrants further study. The change between the 
two  measurements in  khat-induced psychotic experiences in  our  sample was  similar to  the 
changes in subclinical psychotic symptoms in the NEMESIS study (Hanssen et al., 2005), and 
the finding that experiences were not strongly related to true psychotic symptoms was similar to 
other studies on the psychotic continuum (van Os et al., 2009). 
 
 
Khat-induced psychotic experiences can be seen as a marker of individual vulnerability to psy- 
chosis in the sense of a gene x environment interaction (Linney et al., 2003; McDonald et al., 
2001), as has been shown for other non-clinical forms of psychotic presentations (Linney et al., 
 
2003). Our study is compatible with the view that environmental variation is related to patterns of 
psychotic experiences and that vulnerability to psychotic disorders arises from a combination of 
environmental factors. In our sample, the vulnerability marker of khat-induced psychotic experi- 
ences seemed to vary systematically with current khat use (assessed by immunoassay) and expe- 
rience of potentially traumatic events: The prevalence of khat-induced psychotic experiences was 
highest among respondents with a positive khat test and high trauma load or recent trauma expo- 
sure. This association was strongest during the rainy season (T2), when market availability and 
khat use were higher and more respondents reported psychotic experiences; all these factors 
might have lowered the threshold to make this environment-induced vulnerability visible in this 
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specific context. This finding needs to be further examined in longitudinal cohort studies that as- 
sess harms to public mental health with clinical outcomes (e.g. psychotic and other mental disor- 
ders). 
 
 
Our interpretation that the reported findings might be explained in the context of the sensitization 
hypothesis is further strengthened by our more complex analyses. This hypothesis would predict 
that both, recent and lifetime trauma would have measurable effects. In our study we measured 
exposure to potentially traumatic events at T1 and divided the group into subgroups with high 
and low previous trauma exposure. At T2, we assessed traumatic events in the 9 months since T1 
(recent exposure) and divided the group into those with any traumatic events in this period and 
those with at least one such event. Among respondents with a positive immunoassay test and low 
trauma exposure before T1, only those with recent trauma exposure had a higher prevalence of 
khat-induced  psychotic  experiences.  The  prevalence  of  khat-induced  experiences  was  high 
among respondents with a positive immunoassay test and high exposure to traumatic events be- 
fore T1, and recent traumatic events had no additional effect. Our results are compatible with the 
hypothesis that the dopamine system becomes sensitized in the long term to the psychotomimetic 
effects of khat after exposure to traumatic experiences; we showed that experiencing recent trau- 
matic events might be associated with a prevalence of khat-induced psychotic experiences similar 
to that of earlier exposure and that recent exposure might not be related to an increase in khat-in- 
duced psychotic experiences in individuals who already have a high level of exposure. 
 
 
In this study, we additionally validated measures of khat use that require few resources and train- 
ing compared with gold standard assessment tools. We showed that low-resource methods to as- 
sess khat use under field conditions have a high concordance with methods that require highly 
trained staff and sophisticated laboratory environments. We conclude that the assessment of khat 
use by trained local staff and the application of a simple immunoassay test that was originally 
developed for amphetamine assessment are valid research tools. 
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4.2 Adorjan K, Mekonnen Z, Tessema F, Ayana M, Degenhardt F, Hofmann P, Fricker N, Wid- 
mann M, Riedke H, Toennes S, Soboka M, Suleman S, Tesfaye M, Rietschel M, Susser E, Oden- 
wald M, Schulze and Mattheisen M. Genotype-Phenotype feasibility studies on khat abuse, trau- 
matic experiences and psychosis in Ethiopia. Psychiatr Genet. 2019; 30(1):34-38. 
 
 
Introduction 
 
 
 
In addition to our first study reported above (s. publication 4.1), we also performed genome-wide 
genotyping in a smaller subset of our pilot sample (N = 100). This second pilot study was meant 
to show the feasibility of studying the involvement of genetic risk factors and gene-environment 
interactions for sensitization models of psychosis including trauma load and substance abuse. Our 
aim was to investigate the link between mental illness and its environmental and genetic risk fac- 
tors in low-income countries. Studies like these will improve our understanding of how risk fac- 
tors identified predominantly in high-income countries also apply to other settings and will iden- 
tify new, sometimes population-specific risk factors. 
 
 
Methods (s. above) 
 
 
 
Analyses conducted in Ethiopia: We collected blood samples (10 ml venous blood) during the 
T1v assessment of the first study reported above. The samples were transported to the study labo- 
ratory by a cold chain system preserving the integrity of the sample and stored in refrigerators at 
2-8 °C after reaching the laboratory. Subsequently, blood samples were transported to JU and 
 
stored in freezers (-80̊C). For DNA extraction, we established state-of-the-art procedures on site: 
DNA was extracted using chemagic DNA Blood 10k Kits (Perkin Elmer). 
 
 
Analyses conducted in Germany: We tested the quantity and quality of the DNA extracted in lab- 
oratories at JU. The purity and homogeneity of the samples was tested by spectrophotometric 
measurements. For photometric determination of the concentration of DNA, we used Bio Pho- 
tometer technology with absorbance measured at 260 nm. The samples were genome-wide geno- 
typed using the Infinium Global Screening Array BeadChip (Illumina). This BeadChip includes a 
multi-ethnic genome-wide content which was selected at minor allele frequencies of > 1% across 
all 26 1000 Genomes Project populations including cohorts from Africa (Huang et al., 2011; Ha 
et al., 2014; Auton et al., 2015). 
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Results 
 
 
 
The genotyping of all individuals (N=100) in the genetic pilot study was successfully completed 
with high quality; the overall sample call rate was 99.21%. We followed standard quality control 
(QC) protocols to process our data, including filters for call rate, deviations from Hardy-Wein- 
berg equilibrium (HWE), and minor allele frequency (MAF). In total, 2.54% (17,765) of the 
SNPs were removed due to a low call rate (98%), 1.67% (11,401) because of significant devia- 
tions from HWE, and 42.19% (283,074) because of a MAF <1%.  One person was excluded due 
to a call rate <98% and three individuals were removed because they were related within the 
sample ( >0.2 estimated in PLINK after additional QC and LD pruning following standard proto- 
cols) (Purcell et al., 2007). We found no signs of sample contamination (based on inbreeding co- 
efficients). 
 
 
We also performed downstream analyses of our GWAS pipeline to further assess the quality and 
usability of our data. This included a principle component analysis (PCA) using the EIGENSOFT 
software package (with default parameters) as well as an example GWAS on NE concentration in 
urine for our study sample (Li Q et al., 2018). For the PCA we merged our data with the 661 
African samples from the 1000 Genomes dataset. In line with our expectations and previous re- 
ports (Gallego et al., 2015; Fan et al., 2019), samples from GGFRC mapped separately from 
other African populations in the 1000 genomes dataset (s. Figure 6). For the GWAS of the NE 
concentration in urine in the quality-controlled, genotyped markers (n=387,836) we used a linear 
regression (as implemented in PLINK) with PCA components 1-10 as covariates. As expected, 
our GWAS did not reveal any genome-wide significant association (minimum P-value 3.38 x 10- 
7; rs56124025 located on chromosome 3; lambda= 1.015). 
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Legend to Figure 6. ACB: African Caribbean in Barbados (n=96); ASW: Americans of African Ancestry 
in SW USA (n=61); ESN: Esan in Nigeria (n=99); GWD: Gambian in Western Divisions in the Gambia 
(n=113); LWK: Luhya in Webuye, Kenya (n=99); MSL: Mende in Sierra Leone (n=85); YRI: Yoruba in 
Ibadan, Nigeria (n=108); GGFRC: Gilgel Gibe Field Research Center, Southwestern Ethiopia, locat- 
ed 55 km northeast of Jimma City (n=96). PC1: principle component 1; PC2: principle compo- 
nent 2. 
 
 
Conclusion 
 
 
 
Encouraged by the high quality generated during the pilot studies, we are currently preparing the 
full study with a sample size of N=10,000 to study genetic variation and gene-environment inter- 
actions in Ethiopia, especially the relationship of khat abuse with the development of psychotic 
symptoms and its interactions with genetic factors. The GGFRC offers a unique opportunity to 
build well-characterized samples and to perform genetic studies that, till date, have not yet been 
undertaken in Ethiopia at this scale and that will supplement other efforts currently underway in 
Africa. Moreover, we will be in a unique position to study the relationship between khat use, psy- 
chosis, and trauma. The information obtained from this pilot study is instrumental for the prepa- 
ration of a comprehensive genetic study in a developing African country. 
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4.3 Proebstl L, Kamp F, Manz K, Krause D, Adorjan K, Pogarell O, Koller G, Soyka M, Falkai 
P, Kambeitz J. Effects of stimulant drug use on the dopaminergic system: A systematic review 
and meta-analysis of in vivo neuroimaging studies. Eur Psychiatry. 2019;59:15-24. 
 
 
Introduction 
 
 
 
Stimulant drugs such as amphetamine, methamphetamine, and cocaine can cause persistent 
changes in the brain, for example in the striatum. They cause an unbalanced dopaminergic sys- 
tem, which leads to alterations and impairments in the reward system and circuits. This change in 
the reward system combined with withdrawal symptoms is one reason for symptoms of addiction 
for the development of psychotic symptoms (Schultz et al., 1997). Imaging studies with positron 
emission tomography (PET) or single photon emission computerized tomography (SPECT) have 
found differences between stimulant users and healthy controls (e.g. Simon et al., 2004; dela 
Peña et al., 2015).  For amphetamines, most studies reported significantly decreased dopamine 
transporter (DAT) in abstinent heavy users (Johanson et al., 2006) and decreased receptor levels 
in recreational (Schrantee et al., 2016) or former users (Schrantee et al., 2015) compared to 
healthy controls. Other studies showed a negative trend (Schrantee et al., 2016) or no changes in 
recreational users (Schouw et al., 2013) compared to healthy controls. The aim of this analysis 
was to examine differences between users and nonusers of stimulating substances and whether 
these substances differ in their effects on the dopamine system’s function in the striatum. Fur- 
thermore, here we will discuss the results with regard to the sensitization model of psychosis (s. 
publication 4.1). 
 
 
Methods 
 
 
 
This study focused on influences of stimulant use on dopaminergic function assessed using nu- 
clear-medicine imaging (PET/SPECT). Included were 39 studies on 655 cocaine, amphetamine, 
methamphetamine or nicotine users, as well as 690 healthy controls. Meta-analyses were con- 
ducted separately for D2/D3 receptors and dopamine transporters of the entire striatum, its subre- 
gions caudate and putamen respectively. 
KLINIKUM  DER  UNIVERSITÄT  MÜNCHEN  SEITE  34 V O N  80  
 
 
 
Results 
 
 
 
Meta-analyses´ results regarding amphetamine users showed reduced DAT availability in the 
striatum, as well as in the sub regions (s. Figure 7). For DAT availability in the whole striatum, k 
= 2 studies comprising N = 23 users and N = 26 controls were included. The summarized effect 
size was significant with g=-0.95 (95% CI: [-1.54, -0.35], p < 0.01). This result indicates a lower 
DAT availability in the striatum of amphetamine users. When investigating the subregions, k = 2 
studies with N = 23 users and N = 26 controls were included for the comparison of DAT avail- 
ability in the caudate. The summarized effect size was significant with g=-1.01 (95% CI: [-1.61, - 
0.40] p < 0.01). This result indicates a lower DAT availability in the caudate of amphetamine 
users. For the analysis of DAT availability in putamen, k = 3 studies were included with N = 41 
users and N = 37 controls. The summarized effect size was g=-0.27 (95% CI: [-1.57, 1.03], p = 
0.69). There was no evidence for publication bias (p = 0.88), or moderation effects for year of 
publication (p = 0.58), age (p = 0.69), used method (p = 0.54) and minimal duration of abstinence 
(p = 0.41). A significant moderation effect for gender was found (p = 0.01), pointing to a stronger 
negative effect with an increasing ratio of men to the total number of participants. 
 
 
Figure 7. Forest Plot of meta-analysis of striatal dopaminergic function in amphetamine users vs. non 
users 
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Discussion 
 
 
 
This meta-analysis provides evidence that there are ongoing changes in the dopaminergic system 
associated with the use of stimulants. For DAT, the results from the striatum and for the subre- 
gion caudate and putamen showed a down-regulation after amphetamine use. The human brain 
does adapt to changes like these (Ornstein et al., 2000), which might be a reason for cognitive 
impairments like poorer performance in flexibility and memory tasks or spatial working memory 
in chronic amphetamine users (Woicik et al., 2009) compared to healthy controls. The down regu- 
lation process in the striatum might be one reason for craving or even lead to relapses (Härtel- 
Petri et al., 2016) because the endogenous dopamine is no longer enough for sufficient stimula- 
tion (Wang et al., 2013). Thus, effects on the dopaminergic system inferred from this analysis 
may be one reason for addictive behaviors and the development of neurocognitive deficits in 
stimulant users. In terms of the sensitization theory, even down-regulated striatal D2-receptors 
can be in a high-affinity state, showing an increased sensitivity to dopamine agonists and a higher 
reward dependent dopamine release (Flagel et al., 2011; Weidenauer et al., 2017) (s. publication 
4.1). To conclude, this meta-analysis shows evidence for changes in the striatal dopaminergic sys- 
tem under stimulant use but, it also shows the importance of further neuroimaging research. 
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4.4 Abdeta T, Tolessa D, Adorjan K, Abera M. Prevalence, withdrawal symptoms and associated 
factors of khat chewing among students at Jimma University in Ethiopia. BMC Psychiatry. 2017; 
(17):142. 
 
 
Introduction 
 
 
 
Another important aspect of khat consumption is the development of withdrawal symptoms. Re- 
cently, khat chewing has become a common practice among high school, college, and university 
students for recreational purposes and because they believe that it increases their academic per- 
formance (Hussain, 2013; Wakgari et al., 2011). Khat chewers spend long hours chewing and 
then recovering from it, which can lead to a loss of work hours and absenteeism from work and 
classes and potentially result in a decrease in overall national economic productivity and poor 
academic performance among students (WHO 2006; Hussain, 2013). The available literature is 
inconsistent regarding the presence or absence of khat withdrawal symptoms. One study on the 
pharmacological and medical aspects of khat and its social use in Yemen found that when chronic 
khat chewers stop chewing, they develop withdrawal symptoms such as feeling hot in their legs, 
nightmares, mild depression, slight tremor, lethargy, a desire to chew khat, and so on (Al-Motar- 
reb et al., 2002). However, another study on substance abuse in outpatients attending rural and 
urban health centers in Kenya found no signs of khat dependency or withdrawal symptoms (Oth- 
ieno et al., 2000). No research was available on the prevalence, withdrawal symptoms, and asso- 
ciated factors of khat chewing in our study area, and we found no study on khat withdrawal 
symptoms in other regions of Ethiopia. Therefore, the objective of this study was to determine 
the prevalence, withdrawal symptoms, and associated factors of khat chewing among regular un- 
dergraduate students of the main campus at JU to provide additional information on the preva- 
lence of khat chewing and khat withdrawal symptoms. 
 
 
Methods 
 
 
 
The institution-based, cross-sectional study was conducted in January 2016 among 651 regular 
undergraduate students of the main campus at JU. A self-administered, structured questionnaire 
adapted from the literature was used. The questionnaire had three parts: (I) socio-demographic 
information; (II) khat chewing habits and substance use other than khat; and (III) checklist to as- 
sess khat withdrawal symptoms. Collected data were checked for completeness, coded, entered 
into Epidata 3.1 and then exported to SPSS version 20 for Windows for statistical analysis. Bi- 
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variate and multivariate logistic regressions were used to explore the presence of associations and 
identify independent predictors of khat chewing. Variables with a p-value <0.25 in the bivariate 
analysis were entered into multivariate logistic regressions in order to control for potential con- 
founders and calculate adjusted odds ratios with a 95% confidence interval (95% CI). Variables 
with p < 0.05 in the multivariate logistic regressions were considered as significantly associated 
with khat chewing. 
 
 
Results 
 
 
 
The study found that the lifetime and current prevalence of khat chewing among students were 
 
26.3% (95% CI: 24.3, 28.3) and 23.9% (95% CI: 21.94, 25.86), respectively. About 25.7% of 
students started chewing after joining university, and 60.5% of these students started during their 
first year. The main reason given for starting khat chewing was for study purposes (54.6%), fol- 
lowed by socialization purposes (42.3%) (s. Figure 8). Among current khat chewers, 72.9% re- 
ported that they had chewed khat for 1 year or more and 68.2% reported that they had experi- 
enced various withdrawal symptoms. The most frequently reported withdrawal symptoms were 
feeling depressed, craving, and feeling fatigued (s. Figure 9). Male gender, attending a place of 
worship daily/2–3 times per week, cannabis use, smoking cigarettes, and having family members 
currently chewing khat were independently associated with khat chewing. 
 
 
Figure 8. Reasons for starting khat chewing among undergraduate students at JU 
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Figure 9. Withdrawal symptoms reported among undergraduate students at JU 
 
 
 
 
 
 
In addition, we found that the following independent variables are significantly associated with 
khat chewing: male gender, attending a place of worship daily/2–3 times per week, current use of 
ganja/cannabis, current smoking cigarettes and having family members who are current khat 
chewers. Students who had used cannabis at least once during the last month had more than four 
times higher odds of chewing khat than those who did not use it during the last month (AOR 
4.17, 95% CI: 1.6, 11.2) (s. Table 4). 
 
 
 
Table 4. Substance use other than khat and school related factors independently associated with current 
khat chewing among undergraduate students at JU 
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Discussion 
 
 
 
This study found that large numbers of university students chew khat; this is in line with that 
found among students at Jazan University, Saudi Arabia (23.1%) (Rashad et al., 2013) and at 
Haramaya University, Ethiopia (23.6%) (Tesfaye et al., 2014). However, the prevalence is higher 
than that found at Addis Ababa University and Gondar University and at four other colleges in 
North West Ethiopia (Dachew et al., 2015; Kebede et al., 2002). The study gave new ideas re- 
garding khat withdrawal symptoms in Ethiopia: The most frequently reported withdrawal symp- 
toms were feeling depressed, craving, and feeling fatigued. This finding is comparable also to 
DSM-5 stimulant withdrawal diagnostic criterion “B,” which specifies that dysphoric mood and 
two or more of the following physiological changes (fatigue, unpleasant dreams, insomnia or hy- 
persomnia, increased appetite, and psychomotor retardation or agitation) should occur within a 
few hours to several days (Sadock et al., 2015). Factors significantly associated with khat chew- 
ing were male gender, attending a place of worship daily/2– 3 times per week, currently using 
ganja/cannabis, current smoking cigarettes and having family members who chew khat. This 
finding shows that poly-substance use behavior can be found among students with a khat chewing 
habit. They serve as a critical role of providing information to form rational foundation for public 
health policy, prevention and planning to bring change in contributing factors for khat chewing. 
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4.5 Yitayih Y, Abera M, Eliais Tesfaye E, Mamru A, Soboka M, Adorjan K.  Substance use dis- 
order and associated factors among prisoners in a correctional institution in Jimma, Southwest 
Ethiopia: a cross-sectional study. BMC Psychiatry. 2019;18(1):314. 
 
 
Introduction 
 
 
 
Another important aspect of khat consumption is the examination of consumer behaviour among 
specific populations such as prisoners. In this context we conducted three studies: 1) with a focus 
on substance use, 2) on trauma, and 3) on psychopathy. These findings will be presented next. 
 
 
Substance use and criminal behavior are closely related, and a large proportion of substance users 
commit crimes while under the influence of a substance (National Council on Alcoholism and 
Drug Dependence, 2018). According to a U.S. Department of Justice report, in 2004 about one- 
third (32%) of inmates in state facilities reported that they had committed a crime while under the 
influence of drugs (Mumola et al., 2006). Alcohol is a factor in 40% of all violent crimes in the 
USA (National Council on Alcoholism and Drug Dependence, 2018), and alcohol and other 
drugs contribute to 78% of violent crimes, 83% of property crimes, and 77% of public order 
crimes (The National Center on Addiction and Substance Abuse at Colombia University, 2018). 
Inmates with substance abuse problems are more likely to be re-incarcerated, begin their criminal 
careers at an early age and have more contact with the criminal justice system. Additionally, pris- 
oners with substance abuse problems are four times more likely to receive income through illegal 
activities (The National Center on Addiction and Substance Abuse at Colombia University). De- 
spite the contribution of substance use disorder to the global burden of diseases and the high 
prevalence among incarcerated people, little attention is given to this disorder in the general pop- 
ulation and among prisoners in particular (Rounds-Bryant et al., 2007). This is particularly true in 
low-income countries; in Ethiopia, for example, no study has ever examined the prevalence of 
substance use disorder in a prison population. Therefore, this study aimed to assess the preva- 
lence of this disorder and associated factors among prisoners in a correctional institution in Jim- 
ma, Southwest Ethiopia. 
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Methods 
 
 
 
We used a cross-sectional study design to collect data from 336 prisoners from June 5 to July 5, 
 
2017 in the correctional institution in Jimma. Study participants were selected from the total of 
 
1460 prisoners eligible for the study by a systematic random sampling technique, i.e., one partic- 
ipant was randomly selected from every four consecutive admissions in the registration book. Al- 
cohol use disorder (AUDIT), nicotine dependence (FTND), khat abuse (DAST), cannabis use 
disorder (CUPIT), psychopathy (Psychopathy Checklist), adverse traumatic life events (LEC-5), 
and social support (Oslo 3-item Social Support Scale) were assessed. Data were entered into Ep- 
iData version 3.1 and analyzed in bivariate and multivariable logistic regression models with the 
Statistical Package for Social Science version 21. Variables with a P value < 0.05 in the final fit- 
ting model were declared to be associated with the outcome variable. 
 
 
Results 
 
 
 
A total of n = 227 (69.0%) of the participants had a history of substance use. The overall preva- 
lence of substance use disorder was 55.9% and reported a substance use disorder within the 12 
months before imprisonment. The prevalence of khat abuse was 41.9%; alcohol use disorder, 
36.2%; nicotine dependence, 19.8%; and cannabis use disorder, 3.6%. A total of n = 105 partici- 
pants (31.9%) had a history of two or more substance use disorders. The median age at the first 
use of a substance was 16 years (IQR 5), and 44% of the participants started using the substance 
before the age of 15 years. The median duration of substance use was 6 years. The main reasons 
for starting substance use reported by participants were peer pressure (41.8%), recreational rea- 
sons (34.2%), and stress relief (29.3%). Almost all of the prisoners with a substance use disorder 
had not received treatment prior to imprisonment (96.7%), but 66.3% of them were interested in 
receiving treatment (s. Table 5). A third (33.7%), however, wanted to continue using the sub- 
stance after they were released from prison. The median age of participants at the first imprison- 
ment was 24 years. Assault and murder were the most common causes of imprisonment. Most of 
the participants had no previous history of imprisonment, and most of the crimes were not com- 
mitted under the influence of a substance. Among the crimes that were committed under the in- 
fluence of a substance (n = 42/329), n = 24 (57.1%) were committed under the influence of alco- 
hol; n = 14 (33.3%), under the influence of khat; and n = 4 (9.6%), under the influence of 
cannabis. 
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Table 5. Forensic history of prisoners in the correctional institution in Jimma 
 
 
 
 
Multivariable logistic regression showed that four variables were significantly associated with 
substance use disorder: poor social support (adjusted odds ratio [AOR]: 4.41; 95% CI, 2.22– 
8.77), living in an urban setting (AOR: 2.42; 95% CI, 1.33–4.40), psychopathy (AOR: 4.68; 95% 
CI, 1.71–12.78), and a family history of substance use (AOR: 4.39; 95% CI, 2.49–7.79). Prison- 
ers with poor social support were more than four times more likely to develop a substance use 
disorder than prisoners with good social support (AOR:4.41; 95% CI, 2.22–8.77). Also, prisoners 
living in an urban setting were more than two times more likely to have a substance use disorder 
than prisoners living in a rural setting (AOR:2.42; 95% CI, 1.33–4.40). Prisoners with psychopa- 
thy were nearly five times more likely to develop a substance use disorder than those without 
psychopathy (AOR: 4.68; 95% CI, 1.71–12.78). Prisoners with a family history of substance use 
were more than four times more likely to have a substance use disorder than prisoners with no 
family history of substance use (AOR: 4.39; 95% CI, 2.49–7.79) (s. Table 6). 
 
 
Table 6. Multivariable logistic regression analysis for independent predictors of a substance use disorder 
among prisoners (n = 329) in a correctional institution in Jimma 
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Discussion 
 
 
 
Substance use disorder is highly prevalent among prisoners. Our finding that just over half of all 
prisoners had a substance use disorder within 12 months prior to their imprisonment is alarming 
since substance use disorder treatment is not accessible in the prison. If current prevalence rates 
are generalizable to all prisons in Ethiopia, our results suggest that about two thirds of prisoners 
with substance use disorder are interested in receiving treatment; however, almost no prisoners 
with substance use disorder have access to such treatment services. Research has shown that an 
unfortunate consequence of this shortage of treatment services is that offenders quickly return to 
drug use and crime after their release from prison (Kinner et al., 2006; Thomas et al., 2014). With 
regard to the treatment of substance use disorder in prison, therapeutic community intervention 
(TCI) and individual and group therapy are methods that can decrease the rates of re-incarcera- 
tion, drug misuse relapse, and re-arrest (Belenko et al., 1998). This study has substantial clinical 
implications for health services in correctional institutions because it shows the need for man- 
agement plans for acute substance withdrawal and for recovery and rehabilitation support for 
prisoners with substance use disorder. 
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4.6 Yitayih Y, Abera M, Eliais Tesfaye E, Mamru A, Soboka M and Adorjan K.  Trauma expo- 
sure and alcohol use disorder among prisoners in a correctional institution in Jimma, Southwest 
Ethiopia: Across-sectional study. BMC Res Notes. 2019;19;12(1):748. 
 
 
Introduction 
 
 
 
Traumatic events are an almost universal experience among prisoners (Carlson et al., 2010). One 
study found trauma exposure rates ranging from 62.4 to 87.0% among incarcerated adult males 
(Gibson et al., 1999). Another study showed that 22% to 43% of patients with posttraumatic 
stress disorder (PTSD) develop a substance use disorder over the course of their lives (Jacobsen 
et al., 2001). Studies have identified several potential mechanisms such as the behavioral sensiti- 
zation paradigm (Robinson et al., 2015), the self-medication hypothesis (Khantzian, 1986), and 
the high-risk hypothesis (Cottler et al., 1992) to explain the relationship between trauma expo- 
sure and substance use disorders (s. publication 4.1). The vulnerability may be influenced by a 
lack of coping strategies or neurochemical brain changes caused by substance use (Brown et al., 
1994). However, to our knowledge the potential association of traumatic life events with prob- 
lematic alcohol use has not been examined among prison populations in Ethiopia. Therefore, this 
study aimed to assess trauma exposure and AUD in prisoners in the aforementioned correctional 
institution in Jimma. 
 
 
Methods 
 
 
 
We conducted a cross-sectional study in the correctional institution in Jimma over a 4-week peri- 
od (June–July) in 2017. We assessed the presence of AUDs with the Alcohol Use Disorders Iden- 
tification Test (AUDIT). Adverse traumatic life events were evaluated with the Life Events 
Checklist (LEC). We assessed nicotine dependence by the Fagerstrom Test for Nicotine Depen- 
dence (FTND). To evaluate khat abuse we used the Drug Abuse Screening Test (DAST). In addi- 
tion, we used a questionnaire to assess the following variables for AUD: socioeconomic factors 
(age, sex, marital status, ethnicity, religion, educational status, occupation, income); environmen- 
tal factors and behavioral and mental health factors. We assessed social support with the Oslo 3- 
item Social Support Scale and psychopathy with the Psychopathy Checklist (see above). The data 
were exported to the Statistical Package for Social Science version 21.0 for further analysis, and 
binary logistic regression analysis was used for both bivariate and multivariate analysis to ex- 
plore associations and identify variables independently associated with AUD. Factors associated 
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with the outcome variables that had a P value < 0.25 in the bivariate analysis were included in the 
multivariable analysis. Statistical significance was set at P < 0.05. 
 
 
Results 
 
 
 
A total of 329 prisoners participated in the study. The median age of the participants was 26 
years. Of the 329 participants, 209 (63.5%) had lifetime trauma exposure and 132 (40.1%) had 
AUD. Of the 209 prisoners with lifetime trauma exposure, 92 (44.0%) had AUD in the 12 months 
before imprisonment: 44 (21.1%) had hazardous drinking, 16 (7.7%) had harmful drinking, and 
32 (15.8%) had alcohol dependence; 117 (56%) had no alcohol use problem. The most commonly 
encountered types of trauma in the whole group and in the prisoners with AUD were transporta- 
tion accidents (whole group: n = 126, 38.3%; prisoners with AUD: n = 69, 54.8%) and physical 
assault (whole group: n =  91, 27.7%; prisoners with AUD: n =  64, 70.3%). In the whole group, 
146 (44.4%) participants had experienced two and more traumatic events. Among the prisoners 
with AUD (n = 119), 27 (22.7%) had no exposure to a traumatic life event, 23 (19.3%) had expe- 
rienced one traumatic life event, and 69 (58%) had experienced multiple traumatic life events. 
 
 
Multivariable logistic regression showed that experiencing multiple traumatic life events was 
significantly associated with AUD: Prisoners who had experienced multiple traumatic life events 
were almost three times more likely to develop AUD than prisoners with no exposure to a trau- 
matic life event (adjusted odds ratio 2.47, 95% CI:1.23, 4.94) (s. Table 7). 
 
 
Table 7. Multivariable logistic regression analysis for independent predictors of alcohol use disorder 
among prisoners in a correctional institution in Jimma 
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Discussion 
 
 
 
We found that prisoners with trauma exposure were at greater risk for AUD than prisoners with 
no trauma exposure: 92 (44.0%) of the prisoners with lifetime trauma exposure had an AUD in 
the 12 months before imprisonment, compared with 27 (22.5%) of the prisoners without lifetime 
trauma exposure. Participants who had been exposed to multiple traumatic life events had higher 
odds of association for AUD than participants with no exposure to traumatic life events. In the 
present study, the group of people who consumed alcohol was also the group with the highest 
trauma load. Thus, we can assume that the prevalence of PTSD was very high among these re- 
spondents and that they intentionally used substances to better deal with symptoms from the 
PTSD spectrum, according to the self-medication hypothesis (Khantzian, 1986). Although we 
cannot establish clear causality from our data, mental health professionals should recognize that 
multiple traumatic exposures among prisoners may be a particular risk factor for AUD. 
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4.7 Yitayih Y, Soboka M, Tesfaye E, Abera M, Mamaru A, Adorjan K. A cross-sectional study of 
psychopathy and khat abuse among prisoners in the correctional institution in Jimma, Ethiopia. 
PLoS One. 2020;15(1). 
 
 
Introduction 
 
 
 
Psychopathic personality is an important construct that has been linked to criminal behavior and 
problematic substance use, and substance use greatly increases the likelihood that psychopathic 
individuals will engage in serious or violent criminal activity (Steadman et al., 2000). Indeed, a 
large-scale study on aggression and offending found that the best predictor of violence was psy- 
chopathic traits in conjunction with substance use (Steadman et al., 2000). Also khat abuse and 
psychopathy are both strongly related to criminal activity (s. publication 4.5). Higher rates of 
substance use in people with psychopathy are hypothesized to be related to psychopathic person- 
ality traits, which include high sensation seeking, low conscientiousness and neuroticism, impul- 
sivity, and irresponsibility (Leistico et al., 2008). Little is known, however, about the association 
between psychopathy and khat abuse among prisoners in Ethiopia. Therefore, we evaluated the 
presence of these two factors in prisoners in the aforementioned correctional institution in Jimma. 
 
 
Methods 
 
 
 
We conducted a cross-sectional study in the correctional institution in Jimma, from June 5 to July 
 
5, 2017. We assessed khat abuse with the Drug Abuse Screening Test (DAST), a 10-item, self- 
administered questionnaire. Psychopathy was measured with the Psychopathy Checklist: Screen- 
ing Version (PCL: SV). In addition to examining psychopathy and khat abuse, we assessed the 
presence of alcohol use disorders (AUDs) as well as adverse traumatic life events with the Life 
Events Checklist (LEC). Nicotine dependence was assessed by the Fagerstrom Test for Nicotine 
Dependence. We also determined social support with the Oslo 3-item Social Support Scale. Final- 
ly, we used a questionnaire to evaluate the following potential explanatory variables for substance 
use disorder: socioeconomic factors (age, sex, marital status, ethnicity, religion, educational sta- 
tus, occupation, income); environmental factors (family history of substance use, social support, 
immigration history); behavioral and mental health factors (previous known mental illness, per- 
ception that substance use does not impair health, start of substance use at an early age, chronic 
physical illness, suicidal ideation and attempts); and criminal factors (previous arrests, previous 
substance-related offences, type of crime, committed a crime under the influence of a substance). 
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After the tests and questionnaires had been checked for completeness, data were entered into Ep- 
iData Version 3.1 and then exported to the Statistical Package for Social Science version 21.0 for 
further analysis. Descriptive statistics, such as frequencies and medians, were computed, and bi- 
variate and multivariable analyses were used to identify factors associated with the outcome vari- 
ables. All variables associated with khat abuse in the bivariate logistic regression with a P value < 
0.25 were entered together into the multivariable logistic regression by default (enter method) to 
control for potential confounders. Variables with P value <  0.05 were declared to be associated 
with khat abuse in the final model. An odds ratio with a 95% confidence interval (95% CI) was 
calculated to assess the level of association and statistical significance. 
 
 
Results 
 
 
 
A total of 329 prisoners participated in the study. Possible psychopathy was present in 26/329 
participants (7.9%; PCL: SV score . 13 but < 18); and probable psychopathy, in 15/329 (4.6%; 
PCL: SV score .18). Psychopathy symptoms are glib and superficial charm, grandiose self-worth, 
pathological lying, lack of remorse or guilt, callousness and lack of empathy, early behavior 
problems, lack of realistic long-term goals, impulsivity, irresponsibility, failure to accept respon- 
sibility for own actions, juvenile delinquency and adult anti-social. In the total sample, the preva- 
lence of lifetime khat use was 197/329 (59.9%); and of khat abuse, 138/329 (41.9%). Among the 
participants with possible or probable psychopathy, 32/41 (78.0%) had a history of khat abuse, 
and among prisoners with khat abuse, 21/ 138 (15.2%) had possible psychopathy and 11/138 
(8.0%) had probable psychopathy. The most common psychopathic traits were pathological liar 
(18/138; 13.0%) and a history of juvenile delinquency (14/138; 10.1%). The most common 
crimes among prisoners with possible or probable psychopathy were murder 13/41 (31.7%) and 
assault 13/41 (31.7%) (s. Table 8). 
 
 
Table 8. Types of crime committed by prisoners with psychopathy in the correctional institution in Jimma 
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The bivariate analysis found that various socio-demographic, behavioral, mental health, envi- 
ronmental, and criminal factors were associated with khat abuse, as follows: male sex (crude 
odds ratio [COR]: 2.01; 95% CI: 0.77, 5.128; p = 0.156), living in an urban setting (COR: 1.64; 
95% CI: 1.01, 2.65), p = 0.044), psychopathy, multiple traumatic life events, suicidal ideation and 
suicide attempts, family history of substance use, poor social support, immigration history, and 
previous history of imprisonment. These variables were included in the multivariable analysis. 
The multivariable analysis indicated that the following variables were associated with higher 
odds of having khat abuse: psychopathy, family history of substance use, poor social support, 
AUD, and suicidal ideation and suicide attempts (s. Table 9). 
 
 
Table 9. Multivariable logistic regression analysis of independent predictors of khat abuse among prison- 
ers in the correctional institution in Jimma 
 
 
 
 
 
 
Discussion 
 
 
 
In this study, we assessed the co-morbidity of psychopathy and khat abuse among prisoners in the 
correctional institution in Jimma. We found that the prevalence of khat abuse in the 12 months 
before imprisonment was higher in prisoners with possible or probable psychopathy than in those 
with no psychopathy. Psychopathy was one of the factors significantly associated with khat abuse 
in this study, and participants with possible or probable psychopathy had three times higher odds 
of khat abuse than those with no psychopathy. A family history of substance use, poor social sup- 
port, AUD, and suicidal ideation and suicide attempts were also associated with khat abuse. This 
finding is in line with a study performed in England and Wales, which found that psychopathy is 
an important factor for substance use (Coid J et al., 2009). Our findings have implications both 
for future research on the etiology of offending among people who abuse khat and have AUD and 
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for recognizing ways to prevent offending in this group. The presence from an early age of be- 
havioral problems can escalate into delinquency, criminality, and substance use. We hypothesize 
that among life-course–persistent offenders, the antecedents of psychopathic traits emerge very 
early in life. In addition, the study highlights the need to strengthen addiction health services in 
the correctional institution in Jimma and to design and implement long-term management plans 
for recovery and rehabilitation from khat abuse. There was a high prevalence of traumatic life 
event exposure among the prisoners in this study, so we recommend that researchers evaluate 
prisoners for posttraumatic stress disorder (s. publication 4.6). 
KLINIKUM  DER  UNIVERSITÄT  MÜNCHEN  SEITE  51 V O N  80  
 
 
 
5. SUMMARY 
 
 
 
Several potential mechanisms may explain the observed findings of our studies. The most appar- 
ent is that psychotic experiences might be a severity marker of mental health problems and that 
higher khat use and greater experience of traumatic events characterize people with more severe 
mental health problems. The self-medication hypothesis (Boys   et al., 2003; Khantzian, 1985; 
Waldrop et al., 2007) proposes that individuals with more traumatic experiences may use higher 
amounts of substances to alleviate trauma-related psychiatric symptoms, in which case higher 
khat use would fit with the higher rate of psychotic experiences. However, this hypothesis does 
not explain for example the results of our main study (s. publication 4.1), because participants 
with a positive amphetamine test used the same amount of khat irrespective of the number of ex- 
perienced traumatic events. However, possible evidence for the self-mediation hypothesis was 
found in the sub-population of prisoners with AUD and trauma (s. publication 4.6).  The trauma 
hypothesis (Brady et al., 1998; Coffey et al., 2006; Daly, 2000; Jacobsen et al., 2001; Redman et 
al., 2017), i.e. individuals with traumatic experiences are at higher risk to develop psychotic 
symptoms, also fails to explain our results in our main study (s. publication 4.1) because trauma 
was not associated with the prevalence of psychotic experiences among participants with a nega- 
tive khat test. Future studies need to clarify the association between psychotic experiences and 
specific types of traumatic events, e.g. adverse childhood experiences, which were found in other 
studies to influence psychotic symptoms (Alemany et al., 2011). 
 
 
Our findings in the main study (s. publication 4.1) are more in line with the explanation that indi- 
viduals with a high trauma load are sensitized to the psychotomimetic effects of khat use, i.e. 
with the behavioral sensitization paradigm and the sensitization model of psychosis (Howes et 
al., 2009; Robinson et al., 2015). The behavioral sensitization paradigm states that repeated ad- 
ministration of amphetamines or exposure to severe stress can cause a sensitization of dopamine 
neurons, which subsequently release higher amounts of dopamine in response to stress and am- 
phetamine use (Robinson et al., 2015; Vanderschuren et al., 2000). Sensitization of dopaminergic 
neurons is thought to be involved in the development of positive psychotic symptoms and recur- 
rence of psychotic episodes (Robinson et al., 2015) (s. 4.3). The role of the stress x substance use 
interaction as combined environmental risk factors in the sensitization model of psychosis has 
rarely been studied in humans. Yui et al., (2002) showed that exposure to stress can provoke re- 
emergence of psychotic symptoms in prisoners with a history of amphetamine-induced psychosis. 
In longitudinal and cross-sectional studies, childhood traumatic experiences and later tetrahydro- 
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cannabinol use increased the risk of later reporting psychotic symptoms (Konings et al., 2012) or 
developing psychotic disorders (Houston et al., 2008). Support for the sensitization hypothesis 
also comes from studies on psychotic symptoms and disorders in specific khat user groups ex- 
posed to stress. For example, in a sample of 8,124 active Somali militia members the percentage 
of respondents with psychotic symptoms increased with the amount of khat used, and this associ- 
ation was much stronger in respondents with that in those without PTSD (Odenwald et al., 2005). 
In another Somali study in patients with chronic psychosis, age of onset of psychosis was related 
to age of onset of khat use, and increased khat use was related to higher lifetime trauma exposure; 
matched healthy controls showed no such relation (Murray et al., 2013). Future studies should 
specifically test the two potentially meaningful explanatory hypotheses against each other, i.e. 
khat-induced psychotic experiences are markers of more severe mental health or the conse- 
quences of a potential sensitization effect. 
 
 
Our studies potentially add several new aspects to the scientific discussion on the sensitization 
hypothesis. First, we found that in the general Ethiopian male population, and not only in a spe- 
cific subgroup that might be especially prone to substance abuse, the interaction of the environ- 
mental risk factors khat and trauma might act on the development of psychotic experiences simi- 
lar to the interaction of cannabis and trauma (Konings et al., 2012). Second, traumatic experi- 
ences-related sensitization to psychotomimetic effects of substances might involve experiences 
from the whole lifetime and not be limited to childhood experiences. Third, changes in khat 
availability might influence the presentation of khat-induced psychotic experiences, and the sen- 
sitization effect might appear to be larger in the rainy season, when khat is readily available. 
These findings raise the hope that the mechanisms underlying the onset of psychotic symptoms 
and disorders can be further studied and better understood by gene x environment studies in hu- 
mans in countries where khat use is highly prevalent and specific environmental factors (expo- 
sure to stress and central stimulant agents) are present. Future studies that further confirm the hy- 
potheses generated from this study should include different perspectives though. For example, 
population-based genetico-epidemiological studies should examine gene-environment interac- 
tions as well as the development and evaluation of integrated (i.e. focusing on several comorbid 
conditions) and multisectorial (i.e. medical, public health) interventions. 
 
These studies also showed the great need to further explore khat use and its mental health conse- 
quences because khat-related harms, such as the still unrecognized risk to develop severe mental 
disorders, might currently not be correctly classified (Nutt et al., 2010). Exposure to environmen- 
tal stressors, such as food insecurity, violence, and lack of medical care, is high in the low-in- 
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come countries around the Horn of Africa where khat use is prevalent. These high levels of stress 
exposure and khat use and the high prevalence of psychosis in disadvantaged populations call for 
adequate prevention and treatment tools. Furthermore, the complex associations between these 
factors might demand the further development of currently available approaches, such as the 
WHO’s mhGAP intervention guide for mental, neurological, and substance use disorders in non- 
specialized health settings (WHO, 2013). 
 
 
The undoubted strengths of our studies were the repeated cross-sectional assessments of the same 
cohorts, which allowed us to examine associations and consider seasonal effects on consumer 
behavior. In addition, these were one of the first studies with a repeated measurement design to 
examine khat use in the context of trauma history. Moreover, the studies assessed a representative 
cross-sectional cohort in an understudied population (African population, sub-population of pris- 
oners). 
 
 
Our studies also revealed some limitations. First, we did not assess clinical disorders, e.g. PTSD, 
and did not evaluate psychotic symptoms and disorders as an outcome variable. Future studies 
must include psychotic symptoms and disorders as an outcome variable to detect the potentially 
hazardous effects of the studied environmental factors. Second, the screening methods had only 
moderate sensitivities; however, the high specificities enabled us to study our hypotheses. The 
immunoassay test in particular measured high khat use rather than any khat use; this was espe- 
cially evident in the rainy season, when users tended to chew for more hours/week but without 
exceeding the test’s detection threshold. Future studies should use better screening tools. Fur- 
thermore, it would be interesting to evaluate whether participants with PTSD intentionally use 
khat to ameliorate symptoms (self-medication hypothesis s. publication 4.6). In addition, we did 
not include diagnostic measures that could help determine whether participants had khat use dis- 
orders and did not collect additional data on psychotic disorders and other mental health prob- 
lems. We also need much higher case numbers to study the genetic effect of khat use and traumat- 
ic experiences on the development of psychosis (s. publication 4.2). Finally, our studies included 
only men; khat use is a predominantly male phenomenon, and psychotic experiences also differ 
between men and women, so findings might be explained by male characteristics. Future studies 
need to include gender as a factor to identify general mechanisms. 
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6. IMPORTANCE OF THE WORK AND FUTURE PLANS 
 
 
 
A major focus of future research in psychiatric genetics should lie on the inclusion of populations 
currently heavily underrepresented in our studies. If we are truly committed to fighting mental 
illness and all its associated stigma, we will have to turn our back on our immediate surroundings 
and explore whether our approaches to research and therapy work not only in highly selected 
populations of industrialized countries but also in every corner of the world where many people 
suffer from a psychiatric disorder. Given the challenging conditions on site and little courage for 
investments, especially low-income countries have not yet had the chance to participate in global 
genetic collaborations. However, our initial feasibility studies (s. above) conducted in African 
countries are highly promising. Our early findings demonstrate the reliability and validity of bio- 
logical research methods that are necessary for future genetics studies, deliver new insights into 
pathological pathways of mental disorders, underscore the need for further studying psychiatric 
illnesses, and call for adequate prevention and treatment tools. 
 
 
The establishment of innovative scientific projects and of collaborations in the developing world 
are valuable not only for its theoretical use. Research programs have an enormous impact on both 
the socio-economic development as well as on the improvement of mental health care. They have 
a humanitarian aspect and fit the Sustainable Development Goals (SDG) of the United Nations. 
The research infrastructure currently implemented in Southwestern Ethiopia does not only benefit 
the further development of the Ethiopian psychiatric research infrastructure but it also positively 
impacts on the socioeconomic development and the improvement of mental health care in gener- 
al. Service development, education, research, and publications are indispensable for strengthen- 
ing the professional profile of psychiatry and for promoting mental health. Building capacity, 
supporting young scientists, sharing know-how, establishing new research methods, and making 
available the latest achievements in science and technology - all this has led to creating new 
workplaces (two more laboratory staff), to improving the reputation of local universities (high 
impact factor publication in World Psychiatry), to stopping “brain-drain”, and subsequently to 
improving the situation and the treatment options for patients on site after we had completed our 
study. Our biological research project with its special focus on cultural factors opened up new 
scientific insights and helped develop new resources in the country. Research also bears the po- 
tential to change attitudes and long-held beliefs. Through our engagement, our collaborators and 
we ourselves have been able to bring mental health and mental health research in Ethiopia into 
the limelight of public attention. Based on our findings, as well as our studies involving khat ad- 
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diction, various high-level talks between the Gilgel Gibe research group and the Federal Ministry 
of Health have been held since 2017 to discuss addiction rehabilitation and other projects. In co- 
operation with the Ethiopian Psychiatric Association and with the support of the African Associa- 
tion of Psychiatrists, the first regional WPA Congress was held in Addis Ababa in 2018. In this 
context, many creative African initiatives emerged, and the possibilities of international collabo- 
rations were discussed to improve mental health in Africa. In addition, we managed to present 
our work at the United Nations Office on Drugs and Crime (UNODC) in Vienna and developed a 
“UN Document” on “Treatment of Stimulant Use Disorders: Current Practices and Promising 
Perspectives”. Finally in the presence of Bavarian Prime Minister Dr. Markus Söder, the Ethiopi- 
an Minister of State for Foreign Affairs, Dr. Markos Tekle, State Secretary Weigert and other rep- 
resentatives from politics, economy and science of Ethiopia and Germany, we signed a Memo- 
randum of Understanding for the further cooperation between the IPPG (LMU), the Ethiopian 
Academy of Science and the College of Health Sciences of the University of Addis Ababa within 
the framework of a Bavarian-Ethiopian economic forum in April 2019. 
 
 
Relevant publications in socio-economic context not presented here in detail: 
 
 
 
Reta Y, Tesfaye M, Grimma E, Dehning S, Adorjan K.  Public stigma against people with mental 
illness in Jimma Town, South West Ethiopia. PLoS ONE. 2016;11(11): e0163103. doi:10.1371/ 
journal.pone.0163103. 
 
 
Hadera E, Salelew E, Girma E, Dehning S, Adorjan K, Tesfaye M. Magnitude and Associated 
 
Factors  of  Perceived  Stigma  among Adults  with  Mental  Illness  in  Ethiopia.  Psychiatry  J. 
 
2019:8427561. doi: 10.1155/2019/842756. 
 
 
 
Franke ML, Lersner, Essel OQ, Adorjan K, Schomerus G, Gómez-Carrillo A, Tam Ta TM, Böge 
K, Mobashery M, Dettling M, Diefenbacher, Angermeyer MC, Hahn E: The relationship between 
causal beliefs and desire for social distance towards people with schizophrenia and depression: 
Results from a survey of young Ghanaian adults. Psychiatry Res. 2019;(15)271:220-225. 
 
 
Adorjan K, Mulugeta S, Odenwald M, Ndetei DM, Osman AH, Hautzinger M, Wolf S, Othman 
M, Kizilhan JI, Pogarell O, Schulze TG. Psychiatric care of refugees in Africa and the Middle 
East: Challenges and solutions. Nervenarzt. 2017;DOI 10.1007/s00115-017-0365-4. 
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Dehning, S, Jobst, A, Adorjan, K. Mental Health Masters support psychiatric health care in 
 
Ethiopia, MMW Fortschr Med. 2016;158:1. 
 
 
 
Soboka M*, Adorjan K*, Dehning S, Asaminew T, Abera M, Siebeck M, Tesfaye M, Jobst A. 
Evaluation of a Master of Science in Integrated Clinical and Community Mental Health (MSc 
ICCMH) program in Ethiopia. Ger Med Sci. 2018;18 (16):Doc04. doi: 10.3205/000266. 
 
 
Future plans: Our projects can be seen as a set of pilot and feasibility studies to prepare a com- 
prehensive population-based genetico-epidemiological study on various gene-environment inter- 
actions (khat, trauma, psychosis, risk and resilience) which should be carried out in the very near 
future. The infrastructure of GGFRC offers us a unique opportunity to build collectives of multi- 
ple-thousand people in a shortest period of time and to perform genetic studies in a way they 
have not yet been taken in Africa in this form and dimension so far. The extensive epidemiologi- 
cal registration of a population of 60,000 people, the stable population structure, and the quit sta- 
ble environment, such as the urban and rural way of life with all its characteristics of an African 
country provide ideal conditions for this kind of proposition. The population is ideally suited to 
study the impact of polygenic risk profiles of various psychiatric disorders on behavioral traits 
and their interaction with environment. 
 
 
In addition, we will endeavor our best efforts to facilitate the development of mutually beneficial 
collaboration in the following areas: 1) Promote collaborations between German and Ethiopian 
academic institutions and hospitals; 2) Support common scientific research, conferences, and 
workshops; 3) Foster exchange of information e.g. about national standards and legal practices 
(Ethics Committees); 4) Push development of an infrastructure for biological studies (laboratory 
medicine, genetics, biobank); 5) Promote education and teaching; 6) Build up improvement of 
mental health care (rehabilitation, innovations in the field of laboratory medicine, resulting in the 
distribution of new medicines e.g. lithium), and 7) Enhance collaborations with international or- 
ganizations e.g. World Health Organisation (WHO), United Nations (UN), World Psychiatric As- 
sociation (WPA) and local institutions (National Ethics Committee). 
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